Literature DB >> 15937057

The involvement of NK cells in ankylosing spondylitis.

Niva Azuz-Lieberman1, Gal Markel, Sa'ar Mizrahi, Roi Gazit, Jacob Hanna, Hagit Achdout, Raizy Gruda, Gil Katz, Tal I Arnon, Shosh Battat, Ehud Zamir, Muhammed Adawi, Reuven Mader, Ofer Mandelboim.   

Abstract

A role for NK cells in the regulation of autoimmunity has been demonstrated. Since there is a strong association between Ankylosing Spondylitis (AS) and HLA-B27, which is specifically recognized by the NK-inhibitory receptor KIR3DL1, this study evaluated the potential involvement of NK cells in AS. We studied 19 AS patients and 22 healthy volunteer donors and assessed the percentage, activity and receptor expression of peripheral blood NK cells. We also evaluated candidate-inflammatory mediators in sera. We found that AS patients have significantly higher percentages of NK cells. However, we found no differences between the ability of NK cells derived from AS and healthy controls to recognize target cells expressing HLA-B27. Remarkably, we observed that the NK-inhibitory receptor CEACAM1 (carcino-embryonic antigen-cell adhesion molecule) is highly expressed among AS-derived NK cells. Furthermore, engagement of CEACAM1 inhibited NK activity in these patients. Finally, we demonstrated that CEACAM1 expression is induced by IL-8 and SDF-1 (stromal cell derived factor), both of which are present in high levels in the sera of AS patients. These results may indicate that NK cells and CEACAM1 play a role in AS pathogenesis and implicate chemokines in the mechanism of CEACAM1 expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937057     DOI: 10.1093/intimm/dxh270

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  18 in total

1.  Possible role of natural killer cells in pemphigus vulgaris - preliminary observations.

Authors:  J N H Stern; D B Keskin; N Barteneva; J Zuniga; E J Yunis; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2008-03-28       Impact factor: 4.330

2.  IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents.

Authors:  Valderilio Feijó Azevedo; J R Faria-Neto; Andrea Stinghen; Pedro G Lorencetti; Wagner P Miller; Beatriz P Gonçalves; Carla C Szyhta; Roberto Pecoits-Filho
Journal:  Rheumatol Int       Date:  2013-01-08       Impact factor: 2.631

3.  Quantitative Proteomic Analysis of Peripheral Blood Mononuclear Cells in Ankylosing Spondylitis by iTRAQ.

Authors:  Anji Cai; Suwen Qi; Zhuowa Su; Huaqing Shen; Yu Yang; Liang He; Yong Dai
Journal:  Clin Transl Sci       Date:  2015-03-19       Impact factor: 4.689

4.  Mice expressing human ERAP1 variants associated with ankylosing spondylitis have altered T-cell repertoires and NK cell functions, as well as increased in utero and perinatal mortality.

Authors:  David P W Rastall; Fadel S Alyaquob; Patrick O'Connell; Yuliya Pepelyayeva; Douglas Peters; Sarah Godbehere-Roosa; Cristiane Pereira-Hicks; Yasser A Aldhamen; Andrea Amalfitano
Journal:  Int Immunol       Date:  2017-06-01       Impact factor: 4.823

5.  Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.

Authors:  Boyko Kabakchiev; Dan Turner; Jeffrey Hyams; David Mack; Neal Leleiko; Wallace Crandall; James Markowitz; Anthony R Otley; Wei Xu; Pingzhao Hu; Anne M Griffiths; Mark S Silverberg
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

6.  The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction.

Authors:  Lanfen Chen; Zhangguo Chen; Kristi Baker; Elizabeth M Halvorsen; Andre Pires da Cunha; Magdalena B Flak; Georg Gerber; Yu-Hwa Huang; Shuhei Hosomi; Janelle C Arthur; Ken J Dery; Takashi Nagaishi; Nicole Beauchemin; Kathryn V Holmes; Joshua W K Ho; John E Shively; Christian Jobin; Andrew B Onderdonk; Lynn Bry; Howard L Weiner; Darren E Higgins; Richard S Blumberg
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

7.  CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling.

Authors:  Shuhei Hosomi; Zhangguo Chen; Kristi Baker; Lanfen Chen; Yu-Hwa Huang; Torsten Olszak; Sebastian Zeissig; Jing H Wang; Ofer Mandelboim; Nicole Beauchemin; Lewis L Lanier; Richard S Blumberg
Journal:  Eur J Immunol       Date:  2013-06-18       Impact factor: 5.532

Review 8.  The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD.

Authors:  Rimma Goldberg; Natalie Prescott; Graham M Lord; Thomas T MacDonald; Nick Powell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05       Impact factor: 46.802

9.  Role of KIR3DS1 in human diseases.

Authors:  Christian Körner; Marcus Altfeld
Journal:  Front Immunol       Date:  2012-11-01       Impact factor: 7.561

10.  Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Dong Liu; Budian Liu; Churong Lin; Jieruo Gu
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.